EAU Edu Platform on functional urology
Home
Articles
Editorial
Videos
Webcasts
Education
E-courses
Webinars
Infections Curriculum
Male LUTS Curriculum
Guidelines
Events
Home
Articles
Terug
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
Infections Curriculum
Male LUTS Curriculum
Guidelines
Events
Upcoming event
42nd Annual EAU Congress
Home
/
Editorial
Back
MaleLUTS
Nocturia
Bedwetting
Filter
Tags
5-α reductase inhibitors
,
5α-Reductase inhibitors
,
Aanticoagulants
,
Abiraterone
,
Actigraphy
,
Active surveillance
,
Adenotonsillectomy
,
Adjuvant
,
Adolescent
,
ADT
,
Advanced prostate cancer
,
Alkaline phosphatase
,
Alternative splicing
,
Androgen
,
Androgen antagonists
,
Androgen deprivation therapy
,
Androgen pathway blockade
,
Androgen receptor inhibitor
,
Antegrade ejaculation
,
Antiandrogens
,
Anticancer agents
,
Antidiuretic
,
Antimuscarinics
,
Apnea
,
Aquablation
,
ARCHES
,
Arousal
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
AUA24
,
Avanafil
,
BCG
,
BCG therapy
,
BCG-unresponsive disease
,
Benign Prostatic Diseases
,
benign prostatic hyperplasia procedure
,
benign prostatic obstruction
,
BHC80
,
BHP
,
Biochemical recurrence
,
biomarker
,
Biomarkers
,
Biopsy
,
bipolar TURO
,
Bisphosphonates
,
Bladder
,
Bladder capacity
,
Bladder injury
,
Bladder neoplasms
,
Bladder outlet obstruction
,
Bladder trauma
,
Bladder-sparing therapy
,
Bladder-sparing trimodality
,
BNC
,
bobotic simple prostatectomy
,
Bone metastases
,
BOO
,
BOOI
,
BPD
,
BPE
,
BPH
,
BPO
,
BRCA1
,
BRCA2
,
C difficile colitis
,
Cabozantinib
,
Carcinoma
,
Castrate-resistanter
,
Castration-resistant
,
Chemoradiotherapy
,
Chemotherapy
,
Chronic bacterial prostatitis
,
Chronic kidney disease
,
Circadian rhythms
,
Clinical pathways
,
Clinical practice guidelines
,
Clinical staging
,
Clinical trial
,
Clinical trials
,
Cohort study
,
Collaborative care
,
Comorbidity
,
coronary artery disease
,
Corticotropin-releasing factor
,
COVID-19
,
CP/CPPS
,
CPPS
,
Cryosurgery
,
cSP
,
Curriculum
,
Cystectomy
,
Deferred treatment
,
Depression
,
Desmopressin
,
Detrusor
,
Detrusor hypocontractility
,
Detrusor overactivity
,
detrusor underactivity
,
Diagnosis
,
Dihydrotestosterone
,
Disease progression
,
Docetaxel
,
Drug adherence
,
Drug therapy
,
Dutasteride
,
Early recurrence patterns
,
EAU
,
EAU21
,
EAU22
,
EG110A
,
Ejaculation
,
Ejaculation preservation
,
Ejaculatory dysfunction
,
Emission-computed
,
EMUC21
,
EMUC22
,
End-to-side nerve grafting
,
Endoscopic surgery
,
Enuresis
,
Enzalutamide
,
EORTC
,
Epidemiology
,
ERBB2
,
ERCC2
,
Erectile dysfunction
,
Erectile function
,
ERUS22
,
ESMO21
,
ESMO22
,
ESOU Online
,
ESOU21
,
ESOU22
,
ESU Masterclass
,
ESU Masterclasses
,
External beam radiotherapy
,
fecal microbiota transplantation
,
female stress urinary incontinence
,
Fexapotide triflutate
,
Fibrosis
,
Finasteride
,
FMT
,
Focal therapy
,
Fractures
,
Frail patient
,
Frequency volume chart
,
Frozen section
,
Fusion biopsies
,
Gene expression analysis
,
Genomic classifier
,
Genomics
,
Gensini score
,
GL-XPS
,
Glomerular filtration rate
,
GreenLight laser
,
Guidelines
,
Hematuria
,
Herbal medicines
,
herpes simplex virus-1
,
High-risk NMIBC
,
Highlight of the Month
,
HoLEP
,
hormone-sensitive
,
HORRAD
,
HRQL
,
HSV-1
,
Hypogonadism
,
Hypoxia
,
IC/BPS
,
ICS 2026
,
ICS21
,
Image guided biopsy
,
Imaging
,
IMDC risk model
,
Immune checkpoint
,
Immune checkpoint blockade
,
Immunohistochemistry
,
Immunoregulation
,
Immunotherapy
,
Impaired contractility
,
Incontinence
,
Index lesion
,
Indocyanine green
,
Infection
,
Infertility
,
Inflammation
,
Inflammatory biomarkers
,
Innervation
,
Intensity-modulated radiotherapy
,
International Conference on Endourology 2026
,
International Prostate Symptom Score
,
Intravesical therapy
,
IPP
,
IPSS
,
iTIND
,
Kidney cancer
,
Laparoscopic radical cystectomy
,
Laparoscopy
,
Laser Bipolar
,
Laser prostatectomy
,
Laser therapy
,
Local radiotherapy
,
Localised
,
Localized
,
Localized prostate cancer
,
lower urinary tract symptoms
,
LUT
,
LUTS
,
Lymph node excision
,
Lymph node metastases
,
Lymph nodes
,
Lymphadenectomy
,
Major cardiac adverse event
,
Male LUTS
,
male stress urinary incontinence
,
Management of Non-Neurogenic LUTS incl. BPO
,
Mapping
,
Mass spectrometry
,
Masterclass
,
Masterclass on BPO
,
Masterclass on Lasers in urology
,
Masterclass on MIBC
,
Masterclass on NMIBC
,
Masterclasses
,
MDV3100
,
Medical therapy
,
Melatonin
,
Membranous urethra
,
mesh complications
,
mesh erosion
,
mesh removal
,
Meta analysis
,
Meta regression
,
Metabolic syndrome
,
Metastasectomy
,
Metastasis
,
Metastasized
,
Metastatic
,
Metastatic urothelial cancer
,
MetS
,
MIBC
,
Microbiome
,
MicroRNAs
,
Microscopic haematuria
,
Micturition chart
,
midurethral sling
,
Minimally invasive surgical therapy
,
minimally invasive techniques
,
Mirabegron
,
miRNAs
,
Molecular subtypes
,
Monotherapies
,
Mortality
,
Mortality reduction
,
mp-MRI
,
MRI
,
Multiparametric MRI
,
Multiple sclerosis
,
Muscarinic antagonist
,
Neoadjuvant
,
Neoadjuvant chemotherapy
,
Neoplasm metastasis
,
Neoplasm recurrence
,
Neoplasm staging
,
Nephrectomy
,
Nephron-sparing surgery
,
Nephroureterectomy
,
Nerve sparing
,
Neuro-urology
,
neurogenic detrusor overactivity
,
Neuromodulation
,
Neurourology
,
Next-generation sequencing
,
NIBC
,
nitinol
,
Nivolumab
,
Nocturia
,
Nocturia Symposium
,
Nocturia Think Tank
,
Nocturnal enuresis
,
Nocturnal Enuresis and Alarm Treatment
,
Nocturnal Enuresis and Desmopressin
,
Nocturnal Enuresis and Quality of Life
,
Nocturnal polyuria
,
Nocturnal voiding frequency
,
Nomogram
,
non-risk-adjusted cumulative sum
,
Non-visible haematuria
,
Noncastrate
,
Noninvasive
,
Nuclear matrix protein 22
,
NX-1207
,
OAB
,
Obesity
,
Obstructive sleep apnea
,
Obstructive sleep apnea syndrome
,
Oncologic outcomes
,
Online curriculum
,
Open radical cystectomy
,
Optical coherence
,
Orchiectomy
,
Overactive bladder
,
Overall survival
,
Overdiagnosis
,
p53
,
Paediatric Urology
,
Parental punishment
,
Partial nephrectomy
,
Pathogenesis
,
Pathophysiology
,
Patient information
,
Patient satisfaction
,
Patient-reported outcome
,
PCa21
,
PD-L1
,
Pembrolizumab
,
Penile rehabilitation
,
Permixon
,
PET
,
PET/CT
,
Pharmacology
,
Phenotypically directed multimodal management
,
Phosphodiesterase type 5 inhibitor
,
Phosphodiesterase type 5 inhibitors
,
Phytotherapy
,
Placebo effect
,
Plasmakinetic enucleation
,
PLND
,
Positron emission tomography
,
Postoperative complications
,
Potential risk factors
,
POUT trial
,
Precision medicine
,
Pretreatment risk stratification
,
Pretreatment tables
,
Prevention & control
,
Primary tumor treatment
,
Prognosis
,
Prognostic model
,
Prognostication
,
Prospective study
,
Prostasomes
,
Prostate
,
Prostate arterial embolisation
,
Prostate screening
,
Prostate surgery
,
Prostate-specific antigen
,
Prostate-specific membrane antigen
,
Prostatectomy
,
Prostatic
,
Prostatic arterial embolization
,
Prostatic artery embolization
,
Prostatic hyperplasia
,
Prostatic neoplasms
,
Prostatitis
,
ProtecT trial
,
Proteomics
,
PSA
,
PSA flare
,
PSA kinetics
,
PSA screening
,
PSMA PET/CT
,
PTEN
,
PUL
,
QoL
,
Quality of life
,
Radiation therapy
,
Radical cystectomy
,
Radical nephrectomy
,
Radical prostatectomy
,
Radical surgery
,
Radio-chemotherapy
,
Randomized controlled trial
,
Randomized prospective trial
,
Randomized trial
,
Randomized trials
,
Rapid metastasis
,
RARC
,
RASP
,
Rb
,
RB1
,
Receptors
,
Recurrence
,
recurrent SUI
,
Recurrent urinary tract infections
,
Remission
,
Renal cancer
,
Renal cell
,
Renal cell carcinoma
,
Renal cryoablation
,
Renal function
,
Renal function profile
,
Renorrhaphy
,
Retrograde ejaculation
,
Risk stratification
,
RNA splicing
,
Robotic
,
Robotic prostatectomy
,
Robotic radical cystectomy
,
Robotic surgery
,
Robotic Urology
,
Robotics
,
rUTI
,
Salivary alpha-amylase
,
Salvage therapy
,
SATURN registry
,
Screening
,
Sentinel lymph node
,
Serenoa repens
,
Sexual Dysfunction
,
Sexual dysfunctions
,
Sexual quality of life
,
SGLT2-i
,
Sildenafil
,
Simple prostatectomy
,
Sleep quality
,
Sleep-disordered breathing
,
sling explantation
,
Sodium diuresis
,
sodium-glucose cotransporter-2 inhibitors
,
Solifenacin
,
spinal cord injury
,
SREs
,
SRRM4
,
STAMPEDE
,
Stem cells
,
Stereotactic body radiotherapy
,
stress urinary incontinence
,
SUI
,
Surgery
,
Surgical intervention
,
Surgical margins
,
surgical SUI care
,
Surgical video
,
surgical videos
,
Survival outcome
,
SUSTeR study
,
Suture
,
Sympathetic nervous activity
,
synthetic slings
,
Systematic biopsy
,
Systematic review
,
Tadalafil
,
Tamsulosin
,
Targeted Biopsy
,
Targeted therapies
,
Telomerase
,
Tension-free Vaginal Tape
,
Testosterone
,
ThuLEP
,
TITAN
,
TmLRP
,
Tolterodine
,
Tomography
,
TP53
,
Transcriptome
,
Transitional cell
,
Transitional cell carcinoma
,
Transperineal template biopsy
,
Treatment response
,
Tregs
,
Tumor suppressor genes
,
TUR syndrome
,
TURis
,
TURP
,
TVT
,
TVT-hybrid sling
,
Ultrasensitive PSA
,
Ultrasonography
,
Underactive bladder
,
urethral implantable device
,
Urethral injury
,
Urethral trauma
,
urgency urinary incontinence
,
Urinary bladder neoplasms
,
Urinary diversion
,
urinary extracellular vesicles
,
Urinary incontinence
,
Urinary Incontinence in Adults
,
Urinary nerve growth factor
,
Urinary sphincter
,
Urinary tract infection
,
Urodynamic
,
Urodynamics
,
Urodynamics techniques
,
Urolift
,
Urological surgery
,
Urothelial cancer
,
Urothelium
,
UROwebinar
,
UTUC
,
Vardenafil
,
vascular comorbidity
,
Voiding
,
Voiding diary
,
Voiding dysfunction
,
Water diuresis
,
WCRF/AICR CUP
,
Webinar
,
Wnt
,
Zoledronic acid
,
α-Adrenergic blocker
,
α-Adrenoceptor antagonists
,
α-Blocker
,
α-blockers
,
α1-Blockers
Show all
Essential functional urology summer reads
View
Key articles on Urinary tract infections (UITs)
View
EAU22 recommendations
View
AUA2022 recommended abstracts
View
Selected ICS21 abstracts
View
AUA2021 abstracts on BPH/LUTS
View
Milestone publication: Relative Nocturnal polyuria as a factor in enuresis
View
Novel minimally invasive techniques for male LUTS
View
Copeptin in nocturnal enuresis. A biomarker for desmopressin response?
View
ICCS2019: the latest on childhood incontinence
View
How much evidence is needed to prove the association between a condition and a comorbidity?
View
Nocturnal enuresis, bedwetting: myths, fact or fiction?
View
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
I agree
Read more